Turn Therapeutics Inc. (TTRX) income statement
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$8.89+0.34 (+3.98%)
Close on Nov 18, 2026Market cap $264.82MP/E –Yield –
Turn Therapeutics Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -141.7%
Financial strength
- Current ratio
- 3.19
- Debt to equity
- 1.09
- Debt to assets
- 37.8%
- Cash to current liabilities
- 271.2%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 46.52
- Dividend yield
- –
See a number that looks wrong?